CAC
BBOT

Cowen and Company’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Cowen and Company’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45,048
Closed -$471K – 277
2024
Q3 		$471K Sell
45,048
-5,463
-11% -$57.1K 0.02% 168
2024
Q2 		$516K Sell
50,511
-3,902
-7% -$39.9K 0.01% 170
2024
Q1 		$566K Buy
+54,413
New +$566K 0.02% 180